Etan Orgel

Academic / Other · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL B-cell Acute Lymphoblastic Leukemia, Obesity	Phase 2	2022-03-12
No Longer Available	Individual Patient Expanded Access Gilteritinib (ASP2215) AML	—	—